Stoke Therapeutics, Inc.
STOKNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.65B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $20.32$40.22
- Volume (live)
- -
- Avg. volume (3M)
- 1.09M
Stoke Therapeutics (STOK) Stock Price & Financial Analysis
Stoke Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $24.80 - $25.83 |
|---|---|
| 52-Week High | $40.22 |
| 52-Week Low | $20.32 |
| Open | $25.53 |
| Volume (last close) | 2.16M |
| Average Volume (3M) | 1.09M |
| Revenue (TTM) | 27.59M |
|---|---|
| Net Income (TTM) | -207.90M |
| Free Cash Flow (TTM) | -180.68M |
| EPS (TTM) | −$3.38 |
| Profit Margin | -753.60% |
| Operating Margin | -809.69% |
| Return on Equity (ROE) | -60.17% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.65B |
|---|---|
| Shares Outstanding | 66.02M |
| Price to Sales (P/S) | 59.92 |
| Price to Book (P/B) | 4.78 |
| EV/EBITDA | -7.42 |
| 50-Day MA | $28.43 |
|---|---|
| 200-Day MA | $31.18 |
| 1-Year Change | −18.90% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Stoke Therapeutics at a Glance
As of the Oct 23, 2026 close, Stoke Therapeutics (STOK) has a market capitalization of $1.65B. The stock trades at 59.9× sales. Over the trailing twelve months it lost $207.90M on revenue of $27.59M and burned $180.68M of free cash flow. Revenue fell 86.2% year over year.
As of its latest reported balance sheet, it holds $110.00M in cash and securities against $2.68M of debt, a net cash position of $107.32M.
Stoke Therapeutics does not currently pay a dividend.
The share price is down 18.9% over the past year. At $25.04 (the Oct 23, 2026 close) it sits within its 52-week range of $20.32 to $40.22, below its 200-day moving average of $31.18.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $45.11, 80.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Stoke Therapeutics
What is the current stock price for STOK?
As of the Oct 23, 2026 close, STOK stock trades at $25.04. The 52-week range is $20.32–$40.22, with a day range of $24.80–$25.83.
What is the P/E ratio for STOK?
The P/E ratio (Price-to-Earnings) for STOK is shown in the Key Statistics section. This valuation metric helps compare Stoke Therapeutics, Inc. to industry peers.
Does STOK pay dividends?
Stoke Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for STOK?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for STOK is Buy. The average 12-month price target is $45.11, a 80.2% upside from the Oct 23, 2026 close of $25.04.
What is the market cap of STOK?
As of the Oct 23, 2026 close, Stoke Therapeutics's market capitalization is $1.65B, classifying it as a small-cap company. Stoke Therapeutics operates in the Healthcare sector within the Biotechnology industry.